Clinical Trials Directory

Trials / Unknown

UnknownNCT05172453

Mother-to-child Transmission of HBV in China

A Real World, Multi-center Study on Mother-to-child Transmission of Hepatitis B Virus in China

Status
Unknown
Phase
Study type
Observational
Enrollment
50,000 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

In order to evaluate the feasibility of eliminating mother-to-child transmission (MTCT) of hepatitis B virus (HBV) by 2030, a multi-center, prospective cohorts study was conducted to investigate MTCT of HBV in China.

Detailed description

A prospective, multicenter study of pregnant women with HBV infection was conducted from July 2015 up to now in a real world setting in the Shield Project stage Ⅱ. Inclusion criteria was any pregnant women with chronic HBV infection. Pregnant women were excluded if they had a positive serologic test for human immunodeficiency virus or hepatitis C virus or any co-morbidity that might reduce compliance or if they were unable or unwilling to use the mobile health application-Shield APP. Enrolled mothers and infants were prospectively followed until infant post-vaccination serologic testing (PVST) was performed at 7-12 months of age. Demographic data, antiviral treatment history, pregnancy and labour history, co-morbidity, HBV serologic marker tests, HBV DNA tests, liver function tests, mode of delivery, neonatal characteristics (height, weight, head circumference, Apgar score and any major birth defect), breastfeeding and PVST for infants at 7-12 months of age were collected. A mobile health application called "SHIELD" was developed and used in the Shield Project stage Ⅱ to collect data and provide support for communication between mothers and their doctors. All laboratory test reports, questionnaires and other relevant information was uploaded into SHIELD. Participants could consult with their doctors via SHIELD during the follow-up.

Conditions

Interventions

TypeNameDescription
OTHERcomprehensive management algorithm for preventing mother-to-child transmission of HBVTo standardize the clinical management of preventing MTCT of HBV and reduce incidences of MTCT, the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) organized experts to compile the "Management algorithm for prevention of mother-to-child transmission of hepatitis B virus" based on the latest research progress and recently published guidelines, which includes 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immunization are its core contents.

Timeline

Start date
2015-07-01
Primary completion
2025-06-30
Completion
2025-12-31
First posted
2021-12-29
Last updated
2021-12-29

Locations

15 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05172453. Inclusion in this directory is not an endorsement.